首页> 外文期刊>Der Pharmacia Lettre >In vitro amylase and glucosidase inhibitory activities of ethanolic extractof Lactuca runcinata DC.
【24h】

In vitro amylase and glucosidase inhibitory activities of ethanolic extractof Lactuca runcinata DC.

机译:Lactuca runcinata DC乙醇提取物的体外淀粉酶和葡糖苷酶抑制活性。

获取原文
           

摘要

The present study was intented to investigate the in vitro - amylase and - glucosidase inhibitory activities of ethanolic extract from whole plant of Lactuca runcinata (DC.). Postprandial hyperglycemia is a prime characteristic of diabetes mellitus and has been a focus in the therapy for diabetes. Pancreatic -amylase and - glucosidase inhibitors offer an effective technique to lower levels of postprandial hyperglycemia by means of control of starch breakdown. Both the therapeutic methodologies which include diminishing hyperglycemia goes for at inhibiting the enzyme -amylase and - glucosidase. In this study range, herbal remedies are considered convenient for management of Type 2 diabetes with postprandial hyperglycemia because their traditional adequacy and acceptability, low expenses, lesser side effects. The ethanolic extract got was subjected to in vitro alpha amylase and alpha glycosidase inhibitory assay utilizing starch azure as a substrate and porcine pancreatic amylase as the enzyme . The enzyme solutions were premixed with extract at distinctive concentrations (20,40,60,80 and 100 mg/ml). Substrate solutions and colorimetric reagents were added to the reaction. The release of glucose was measured by spectrophotometric method. Acarbose was utilized as the positive control. The extract (20- 100 mg/ ml) totally inhibit - amylase and - glucosidase activities. The extract produced higher reduction of α-glucosidase activity than α-amylase. Inhibition at various concentrations were significantly different (p0.05).The results demonstrated a significant (more than 80%) reduction in - amylase and additionally 90% reduction in - glucosidase activity. This finding gives the utilization of ethanolic extract of whole plant of Lactuca runcinata effective in inhibiting -amylase and -glucosidase thereby proving to be potential hostile to hyperglycemic agents.
机译:本研究的目的是研究乳汁乳杆菌全株乙醇提取物的体外淀粉酶和葡糖苷酶抑制活性。餐后高血糖是糖尿病的主要特征,并且一直是糖尿病治疗的重点。胰腺淀粉酶和葡萄糖苷酶抑制剂提供了一种有效的技术,可通过控制淀粉分解来降低餐后高血糖水平。包括减少高血糖症的两种治疗方法都用于抑制酶-淀粉酶和-葡糖苷酶。在该研究范围内,草药被认为可方便地治疗餐后高血糖的2型糖尿病,因为它们具有传统的充分性和可接受性,低费用,副作用较小。以淀粉天青酶为底物,以猪胰淀粉酶为酶对乙醇提取物进行体外α-淀粉酶和α-糖苷酶抑制试验。将酶溶液与提取物以独特的浓度(20、40、60、80和100 mg / ml)预混合。将底物溶液和比色试剂加入反应中。通过分光光度法测量葡萄糖的释放。阿卡波糖用作阳性对照。提取物(20-100 mg / ml)完全抑制淀粉酶和葡萄糖苷酶的活性。该提取物比α-淀粉酶产生更高的α-葡萄糖苷酶活性降低。在不同浓度下的抑制作用显着不同(p <0.05)。结果表明-淀粉酶显着降低(超过80%),另外-葡萄糖苷酶活性降低90%。该发现提供了对抑制-淀粉酶和-葡萄糖苷酶有效的Runactata Lactuca全株乙醇提取物的利用,从而被证明可能对抗高血糖剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号